Clobazam and Keflet drug interactions - a phase IV clinical study of FDA data
Summary:
We study 14,408 people who take Clobazam (clobazam) and Keflet (cephalexin). There is no drug interaction reported.
The study analyzes what interactions people have when they take Clobazam and Keflet. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Clobazam?
Clobazam has active ingredients of clobazam. eHealthMe is studying from 14,399 Clobazam users. Check the latest studies of Clobazam.
What is Keflet?
Keflet has active ingredients of cephalexin. eHealthMe is studying from 9 Keflet users. Check the latest studies of Keflet.
No report is found.
Do you take Clobazam and Keflet?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Related publications that referenced our studies
- Agrawal A, Rao M, Jasdanwala S, Mathur A, Eng M, "Cephalexin Induced Cholestatic Jaundice", Case reports in gastrointestinal medicine, 2014 Aug .
- Agrawal A, Rao M, Jasdanwala S, Mathur A, Eng M, "Cephalexin Induced Cholestatic Jaundice", Case reports in gastrointestinal medicine, 2014 Aug .
How the study uses the data?
The study uses data from the FDA. It is based on clobazam and cephalexin (the active ingredients of Clobazam and Keflet, respectively), and Clobazam and Keflet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ruxience and Chest Pain for Women aged 20-29 - 2 seconds ago
- Ruxience and Painful Chest for Women aged 20-29 - 3 seconds ago
- Ruxience and Chest Tightness for Women aged 20-29 - 3 seconds ago
- Ruxience and Chest Tightness Or Pressure for Women aged 20-29 - 3 seconds ago
- Ruxience and Chest Discomfort for Women aged 20-29 - 3 seconds ago
- Viekira Pak and Nasopharyngitis for Men aged 60+ - 5 seconds ago
- Malignant Urinary Tract Neoplasm and Pain In Extremity - 5 seconds ago
- Niaspan and Weakness for Men aged 30-39 - 7 seconds ago
- Mesalamine and Nasopharyngitis for Men aged 40-49 - 7 seconds ago
- Niaspan and Muscle Fatigue for Men aged 30-39 - 8 seconds ago